Get the latest news, insights, and market updates on GV (Visionary Holdings Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Visionary Holdings (NASDAQ: GV) Provides 2026–2027 Growth Outlook; RAMU Anti-Aging Product Line Targets Potential $30 Million Annual Sales
Company Continues Expansion into North America and Europe as Part of Global Medical Aesthetics StrategyHONG KONG, March 05, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“Visionary” or the “Company”), a technology-driven multinational enterprise focused on healthcare services, medical aesthetics, and advanced biotechnology applications, today provided its 2026–2027 business outlook and strategic growth priorities as the Company continues executing its expansion into global healt Mar 5, 2026 - $GV
Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses
HONG KONG, March 02, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“the Company”), a technology-driven multinational and biotechnology and healthcare-focused company, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited (“GV Hong Kong”), today announced the signing of a US$12 million exclusive distribution agreement for its flagship anti-aging product, Premier Regenerative Complex---President Super Injection, in cooperation with Huajin Chin Mar 2, 2026 - $GV
Visionary Holdings Announces Continued Progress of Approximately US$9 Million Sales Contract
Expects Significant Milestone Advancement by the End of March 2026HONG KONG, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“the Company”), a technology-driven multinational enterprise, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited (“GV Hong Kong”), continued execution progress under its previously signed commercial sales agreement with a total contract value of approximately US$9 million. The agreement, signed in September 2 Feb 24, 2026 - $GV
Visionary Holdings (Nasdaq: GV) Establishes Three Wholly Owned Subsidiaries in Qingdao, Wuxi and Wuhu, Advancing Commercial Expansion in China
HONG KONG, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (“GV” or the “Company”) (Nasdaq: GV), a technology-driven multinational enterprise, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited, has established three new regional wholly owned subsidiaries in Qingdao, Wuxi and Wuhu, China. These subsidiaries are primarily dedicated to localized market expansion, institutional partnerships, and frontline sales execution for GV’s regenerative medic Feb 18, 2026 - $GV
Visionary Holdings Inc. Secures $450,000 in Debt Financing
TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“Visionary” or the “Company”) announced today that in December 2025 it entered into a securities purchase agreement with an existing institutional investor (the “Investor”). In connection with the transaction, the Company issued to the Investor a senior secured convertible promissory note in the principal amount of $500,000 (the “December 2025 Note”) in exchange for gross proceeds of $450,000. As previously disclose Feb 13, 2026 - $GV
Visionary Holdings Inc. Announces Resolution of Nasdaq Filing Deficiency and Confirmation of Continued Listing
MARKHAM, Ontario, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (Nasdaq: GV) (the “Company”), a high-growth technology company specializing in innovative software solutions for the aesthetic medicine industry and cutting-edge advancements in stem cell research, today announced that it has received two formal communications from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) relating to the Company’s periodic reporting status. On January 27, 2026, the Feb 4, 2026 - $GV
Visionary Holdings Inc. Regains Compliance with Nasdaq Periodic Filing Requirement
TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (“GV” or the “Company”), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) in connection with the filing of its Annual Report on Form 20-F for the fiscal year ended March 31, 2025. As previously disclosed, on August 5, 2025, the Company was notified by Nasdaq that it was not in compliance with the periodic filing Feb 2, 2026 - $GV
CORRECTION – Visionary Holdings Inc. Releases Final Fiscal Year 2025 Annual Report and Audited Financial Statements; Form 20-F Filing Pending
TORONTO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- In a release issued under the headline "CORRECTION – Visionary Holdings Inc." on Tuesday, January 13th by Visionary Holdings Inc. (Nasdaq: GV), please be advised there was an error in the attached Form 20-F PDF. The corrected release with the corrected attachment follows: Visionary Holdings Inc. Releases Final Fiscal Year 2025 Annual Report and Audited Financial Statements; Form 20-F Filing Pending Highlighting Strategic Transformation and Early Commerc Jan 21, 2026 - $GV
CORRECTION – Visionary Holdings Inc.
TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- In a release issued under the headline "Visionary Holdings Inc. Reports Fiscal Year 2025 Annual Report" on Monday, January 12th by Visionary Holdings Inc. (Nasdaq: GV), please be advised that the headline and content have been updated to accurately reflect comments from the U.S. Securities and Exchange Commission. The corrected release follows: Visionary Holdings Inc. Releases Final Fiscal Year 2025 Annual Report and Audited Financial Statements; Form 2 Jan 14, 2026 - $GV
Visionary Holdings Inc. Reports Fiscal Year 2025 Annual Report
Highlighting Strategic Transformation and Early Commercial Progress in Emerging Health BusinessesTORONTO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (Nasdaq: GV) (the “Company”) today announced the disclosure of its Annual Report on Form 20-F for the fiscal year ended March 31, 2025, outlining the Company’s strategic transformation, business restructuring progress, and financial performance. During the reporting period, the Company continued to advance its transition from a tradit Jan 13, 2026 - $GV
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple